多家上市公司股东、高管提前终止减持计划

Group 1 - On the first trading day of 2026, several companies with market capitalizations below 10 billion announced the early termination of their share reduction plans [1][2] - Hezhong China disclosed that its controlling shareholder planned to reduce its stake by up to 796.1 million shares, representing 2% of the total share capital, but decided to terminate the plan early due to meeting funding needs and expressing confidence in the company's future [1] - Hezhong China's stock price has been rising since late October, despite warnings of performance decline and losses due to macroeconomic changes and policy adjustments in the medical industry [1] Group 2 - As of January 5, Hezhong China's total market value is 9.2 billion [2] - Haisen Pharmaceutical announced that some directors and senior management completed their share reduction plans, while one executive, based on confidence in the company's future, decided to terminate their plan early [2] - The financial director of Haisen Pharmaceutical reduced 3,000 shares during the planned period, while other executives completed their reductions totaling 102,900 shares, representing 0.0675% of the total share capital [2] Group 3 - AoJing Medical disclosed that its executives decided to terminate their share reduction plans early due to market conditions and personal circumstances [3] - Executives at AoJing Medical had previously planned to reduce their stakes from December 3, 2025, to March 3, 2026, but opted to halt the plan [3] - The reductions by executives at AoJing Medical accounted for 0.07%, 0.05%, 0.04%, and 0.03% of the total share capital, respectively [3]